Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer. [electronic resource]
Producer: 19950921Description: 7-12 p. digitalISSN:- 0093-7754
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Clinical Trials, Phase II as Topic
- Cohort Studies
- Creatinine -- urine
- Dose-Response Relationship, Drug
- Drug Tolerance
- Filgrastim
- Glomerular Filtration Rate
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Infusions, Intravenous
- Lung Neoplasms -- drug therapy
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Recombinant Proteins -- therapeutic use
- Remission Induction
- Thrombocytopenia -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.